Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0001127602-22-019051

Chief Scientific Officer sold 4,415 shares at $1.53 ($6,755)

  • Chief Scientific Officer acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Loose Christopher R. · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-07-05 Exercise or conversion : show line 1 in the form +15,000 54,465 D
2022-07-06 Sale : show line 2 in the form −4,415 $1.53 $6,755 50,050 D
Open-market sales · 4,415 sh · avg $1.53 · $6,755

Table II: Derivative

1 line
Date Transaction Shares Underlying Owned after D/I
2022-07-05 Exercise or conversion : show line 3 in the form Restricted Stock Unit −15,000 15,000 0 D
Loading xslF345X03/form4.xml…